• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities.

作者信息

Vatrella Alessandro, Maglio Angelantonio

机构信息

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

出版信息

Expert Rev Respir Med. 2025 Jan;19(1):1-5. doi: 10.1080/17476348.2024.2449080. Epub 2025 Jan 5.

DOI:10.1080/17476348.2024.2449080
PMID:39749409
Abstract
摘要

相似文献

1
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities.实现重度哮喘的持续缓解：目标、挑战、问题与机遇。
Expert Rev Respir Med. 2025 Jan;19(1):1-5. doi: 10.1080/17476348.2024.2449080. Epub 2025 Jan 5.
2
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.美泊利单抗治疗重度嗜酸性粒细胞性哮喘的长期临床疗效及持续缓解：REMI-M研究
J Allergy Clin Immunol Pract. 2024 Dec;12(12):3315-3327. doi: 10.1016/j.jaip.2024.08.033. Epub 2024 Aug 27.
3
Challenges and Opportunities in Achieving Asthma Remission.实现哮喘缓解的挑战与机遇
J Clin Med. 2025 Apr 20;14(8):2835. doi: 10.3390/jcm14082835.
4
Biologics in Asthma: Potential to Achieve Clinical Remission.哮喘中的生物制剂：实现临床缓解的潜力。
Immunol Allergy Clin North Am. 2024 Nov;44(4):725-736. doi: 10.1016/j.iac.2024.08.004. Epub 2024 Sep 6.
5
The Relationship of Asthma Biologics to Remission for Asthma.哮喘生物制剂与哮喘缓解的关系。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1090-1098. doi: 10.1016/j.jaip.2020.10.035. Epub 2020 Oct 28.
6
The role of biologics in inducing remission in asthma.生物制剂在诱导哮喘缓解中的作用。
Ann Allergy Asthma Immunol. 2025 Jan;134(1):19-30. doi: 10.1016/j.anai.2024.09.021. Epub 2024 Oct 9.
7
Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.成人德国哮喘网络严重哮喘登记处队列中生物制剂治疗的反应和临床缓解。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2701-2712.e2. doi: 10.1016/j.jaip.2023.05.047. Epub 2023 Jun 8.
8
Barriers to clinical remission in severe asthma.重度哮喘临床缓解的障碍
Respir Res. 2024 Apr 24;25(1):178. doi: 10.1186/s12931-024-02812-3.
9
Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission.携带白细胞介素4（CC变异体）的年轻重度哮喘患者接受度普利尤单抗治疗更有可能实现临床缓解。
BMC Pulm Med. 2025 Mar 21;25(1):131. doi: 10.1186/s12890-025-03578-0.
10
Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method.定义重度哮喘的临床缓解：海湾地区采用改良德尔菲法的专家意见
Respir Med. 2025 Jul;243:108132. doi: 10.1016/j.rmed.2025.108132. Epub 2025 May 3.

引用本文的文献

1
Patient response and remission in respiratory disease: Special focus on severe asthma and chronic obstructive pulmonary disease.呼吸系统疾病中的患者反应与缓解：特别关注重度哮喘和慢性阻塞性肺疾病
J Int Med Res. 2025 May;53(5):3000605251340894. doi: 10.1177/03000605251340894. Epub 2025 May 20.
2
Challenges and Opportunities in Achieving Asthma Remission.实现哮喘缓解的挑战与机遇
J Clin Med. 2025 Apr 20;14(8):2835. doi: 10.3390/jcm14082835.